Moolec Science (NASDAQ:MLEC) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Moolec Science (NASDAQ:MLEC) from a sell rating to a hold rating in a research report sent to investors on Saturday morning.

Moolec Science Price Performance

MLEC opened at $7.28 on Friday. The company has a market capitalization of $5.31 million, a PE ratio of -0.22 and a beta of -0.36. Moolec Science has a fifty-two week low of $3.08 and a fifty-two week high of $157.05. The business has a 50-day moving average of $9.44 and a 200-day moving average of $7.99.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Moolec Science stock. Citadel Advisors LLC acquired a new stake in Moolec Science SA (NASDAQ:MLEC) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned about 0.90% of Moolec Science at the end of the most recent quarter. Institutional investors own 0.07% of the company’s stock.

Moolec Science Company Profile

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.